Emapalumab for children with severe aplastic anemia
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether a medication called emapalumab can help children with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. It combines emapalumab with standard immune-suppressing therapy to try to improve blood cell counts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 25 years old and have been diagnosed with severe aplastic anemia, meaning your bone marrow is very low in cells and you have low counts of at least two types of blood cells (such as neutrophils, platelets, or reticulocytes).
- You have not had any previous treatment for severe aplastic anemia.
- You do not have leukemia, myelodysplastic syndrome, or an inherited bone marrow failure condition.
- You are able to take the study medication and follow the treatment plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding romiplostim to standard care for severe aplastic anemia (a condition where the bone marrow doesn't make enough blood cells) in patients aged 2 to 21. It aims to see if this combination improves blood cell counts in those newly diagnosed or whose disease has come back or not responded to prior treatment.
This trial tests a “half-matched” stem cell transplant for children and teens with severe aplastic anemia when a fully matched donor isn’t available. It may help rebuild blood-making cells after prior treatments did not work well enough.
This study tests a new antibody drug (anti-CD38) for people with severe aplastic anemia that has not responded to or has come back after standard treatments. The goal is to see if this drug can help improve blood counts when other options have failed.
This study tests a drug called emapalumab to help people whose blood counts stay low for weeks after CAR T-cell therapy for certain types of lymphoma. The goal is to see if the drug can help the body recover normal blood cell production.
This trial tests a drug called romiplostim (Nplate) for patients whose aplastic anemia—a rare blood disorder where the bone marrow stops making enough blood cells—didn't improve after cancer treatment and hasn't responded to other medications. The drug may help your bone marrow produce more blood cells.
This trial tests a combination of four medicines (cyclosporine, eltrombopag or hetrombopag, romiplostim, and supportive care) for newly diagnosed aplastic anemia—a serious blood disorder where the bone marrow stops making enough blood cells. The goal is to help your bone marrow work better and reduce your need for blood transfusions.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.